EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing me...
Read more at ABC News
Topics
-
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Health - ABC News - October 31 -
EU fines world’s largest generic drugmaker Teva for hindering competition
Business - Financial Times - October 31 -
Teva Fined Around $500 Million Over MS Drug Competition Concerns
Business - The Wall Street Journal - October 31 -
EU Commission takes Germany to court over capital gains tax deferral
World - Yahoo News - November 14 -
Chancellor and BoE governor call for UK to rebuild ties with EU
Business - Financial Times - 6 days ago -
Britain’s bold plan to create super funds
Business - Financial Times - November 14 -
EU Commission chief urges North Macedonia's political parties to cooperate on accession push
World - ABC News - October 24 -
EU leader praises Serbia for its advances in EU membership bid despite growing Russian influence
World - ABC News - October 25
More from ABC News
-
Prak Sokhonn reappointed as Cambodia's foreign minister
World - ABC News - Yesterday -
About 1,500 migrants form a new caravan in Mexico. Here's what it means
World - ABC News - 17 hours ago -
Elections in 2 Indian states are seen as a test of Prime Minister Modi's popularity
World - ABC News - 16 hours ago -
American and Australian tourists die in Laos alcohol poisoning incident, raising death toll to 4
World - ABC News - 13 hours ago -
Hong Kong activist Jimmy Lai denies he asked a newspaper colleague to draft list of sanction targets
World - ABC News - 8 hours ago